San Diego Marriott Del Mar, 11966 El Camino Real, San Diego, California, 92130, United States
Bringing together technical case studies with actionable insights, the 2nd TPD Assay Development and Screening Summit returns as the first and only industry-dedicated conference to support in-house assay development and screening strategies to find new targets, uncover novel ligands, unravel the MOA, progress beyond CRBN and VHL, improve high throughput methods and progress from early discovery to drug candidate with scalable compounds.
With promise shown using technologies like DELs, CryoEM and HDX-MS, join us as we take a deep dive into the persisting challenges holding back the progression of candidates into pre-clinical studies by exploring the best methodologies at your disposal across AI/ML guided structure-based drug design, proteomics-led, or cell-based assay approaches.
Elevate your quality control strategies with the 2nd PAT and Real Time Quality Summit. Esteemed names like Bristol Myers Squibb, Vertex, Moderna, and more unite this December to redefine real-time quality approaches for novel modalities. Learn from leaders in machine learning, driving real-time control and diversion advancements. Witness the ROI of process analytical technology in drug development and GMP settings through increased yield, predictive modeling, and quicker time to market. Engage with 60+ PAT experts, including process and analytical development leaders, for a comprehensive playbook on successful process analytical tech integration. Date and Time: December 5-7, 2023.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our